secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0001023024-24-000007
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI Pharmaceuticals to present at Guggenheim Healthcare Talks Biotechnology Conference
--------------------------------------------------------------------------------

- CEO Nikhil Lalwani and senior leadership to present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Feb 8, 2024.
- Investor presentation dated February 2024 attached as Exhibit 99.1.
- Disclosure made under Items 2.02 and 7.01 of Form 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000102302424000007/0001023024-24-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000102302424000007/ani-20240208.htm
  HTML page:      https://secwatch.observer/filing/0001023024-24-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer